A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
NCT02935153
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Lymphoma
Interventions
BIOLOGICAL:
Anti-CD22-CAR-transduced T cells
Sponsor
Southwest Hospital, China